+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Therapeutic Space (Oncology, Neurodegenerative Diseases), By Application, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 80 Pages
  • July 2024
  • Region: Global
  • Grand View Research
  • ID: 5595828
Description Jump to:
The global artificial intelligence in drug discovery market size was estimated at USD 9.1 billion in 2030, and is expected to expand at a CAGR of 29.7% from 2024 to 2030. It is expected to expand at a CAGR of 29.6% from 2023 to 2030. The pandemic has made the adoption of AI more widespread in the pharma industry. AI and its related platforms aim to enhance medical imaging and diagnostics, management of chronic diseases, and drug designing. The overall human hours spent would be far more in comparison to the AI system scanning the same data, which reduces overall cost and is a more feasible approach.

The drug optimization and repurposing application segment held the largest revenue share in 2022. AI platforms help in the identification of target proteins for drugs to determine adverse events and possible side effects the drug can have. Drug molecules can be repurposed to make them more effective and with minimum side effects. Portfolio drugs for a company can be altered and studied using AI platforms at a much faster pace so as to hasten new drug development.

The oncology therapeutic area segment accounted for the largest revenue share in 2022. The majority of the pharmaceutical companies are pairing up with AI start-ups to optimize their cancer research, which is still an unchartered territory and there is a lot to be discovered. AI systems can identify cancer much earlier than a regular scan would indicate to even a thoroughly trained radiologist. This, in turn, can increase life expectancy and can also help identify markers to be studied for cancer research and drug development. Patients can be prescribed treatments suited to their genetic composition.

North America dominated the market in 2022. Many tech companies are now investing their money and efforts toward the use of AI in pharmaceutical companies. Companies like IBM, Microsoft, and other tech giants have formed collaborations with research institutes for faster drug development and clinical trials for multiple indications. Developing countries are also finding cost-effective measures to implement AI technology for their drug development and disease understanding.

Artificial Intelligence In Drug Discovery Market Report Highlights

  • The drug optimization and repurposing application segment dominated the market and accounted for a revenue share of over 53.9% in 2022
  • By therapeutic area, the oncology segment held the largest revenue share of over 23.4% in 2022. The infectious diseases segment is expected to register the fastest growth rate during the forecast period
  • Asia Pacific is expected to expand at the fastest CAGR from 2023 to 2030. This can be attributed to the increasing adoption of AI among the developing countries in this region as a means to understand diseases and aid drug discovery
  • North America led the market and accounted for a revenue share of over 58.0% in 2022. The U.S. is significantly contributing to the regional market growth as the country has been the forerunner in the artificial intelligence technology


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 Segment Share Calculation
1.5 List of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Global Artificial Intelligence (AI) in Drug Discovery Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Artificial Intelligence (AI) in Drug Discovery Market Dynamics
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.2.4 Global Artificial Intelligence (AI) in Drug Discovery Market: Pestle Analysis
3.2.5 Global Artificial Intelligence (AI) in Drug Discovery Market: Porter’s Analysis
Chapter 4 Global Artificial Intelligence (AI) in Drug Discovery Market: Application Estimates & Trend Analysis
4.1 Artificial Intelligence (AI) in Drug Discovery Market: Application Movement Analysis
4.2 Drug Optimisation and Repurposing
4.2.1 Drug Optimisation and Repurposing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.3 Preclinical Testing
4.3.1 Preclinical Testing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
4.4 Other Applications
4.4.1 Other Applications Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 5 Global Artificial Intelligence (AI) in Drug Discovery Market: Therapeutic Area Estimates & Trend Analysis
5.1 Artificial Intelligence (AI) in Drug Discovery Market: Therapeutic Area Movement Analysis
5.2 Oncology
5.2.1 Oncology Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.3 Neurodegenerative Diseases
5.3.1 Neurodegenerative Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.4 Cardiovascular Disease
5.4.1 Cardiovascular Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.5 Metabolic Diseases
5.5.1 Metabolic Diseases Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.6 Infectious Disease
5.6.1 Infectious Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
5.7 Others
5.7.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 6 Global Artificial Intelligence (AI) in Drug Discovery Market: Regional Estimates & Trend Analysis
6.1 Global Artificial Intelligence (AI) in Drug Discovery Market Movement Ananlysis, By region
6.2 Global Artificial Intelligence (AI) in Drug Discovery Market Share, By region, 2021 & 2030
6.3 North America
6.3.1 North America Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.2 U.S.
6.3.2.1 U.S. Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.3 Canada
6.3.3.1 Canada Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.4 Mexico
6.3.4.1 Mexico Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4 Europe
6.4.1 Europe Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.2 U.K.
6.4.2.1 U.K. Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.3 Germany
6.4.3.1 Germany Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.4 France
6.4.4.1 France Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.5 Spain
6.4.5.1 Spain Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.6 Italy
6.4.6.1 Italy Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.7 Denmark
6.4.7.1 Denmark Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5 Asia Pacific
6.5.1 Asia Pacific Artificial intelligence (AI) in drug discovery market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.2 China
6.5.2.1 China Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.3 India
6.5.3.1 India Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.4 Japan
6.5.4.1 Japan Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.5 Australia
6.5.5.1 Australia Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.6 South Korea
6.5.6.1 South Korea Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6 Latin America
6.6.1 Latin America Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.6.2 Brazil
6.6.2.1 Brazil Artificial Intelligence (AI) in Drug Discovery Market
6.6.3 Argentina
6.6.3.1 Argentina Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7 MEA
6.7.1 MEA Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7.2 South Africa
6.7.2.1 South Africa Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7.3 Saudi Arabia
6.7.3.1 Saudi Arabia Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7.4 UAE
6.7.4.1 UAE Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.7.5 Kuwait
6.7.5.1 Kuwait Artificial Intelligence (AI) in Drug Discovery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
7.3. Competitive Dashboard & Company Market Position Analysis
7.3.1 Synergy Analysis: Major Deals & Strategic Alliances
7.3.2 List Of Key Emerging Companies /Technology Disruptors/Innovators
Chapter 8 Competitive Landscape
8.1 IBM
8.1.1 Company Overview
8.1.2 Finanacial Performance
8.1.3 Offerings
8.1.4 Strategic Initiatives
8.2 Exscientia
8.2.1 Company Overview
8.2.2 Finanacial Performance
8.2.3 Offerings
8.2.4 Strategic Initiatives
8.3 GNS Healthcare (In January 2023, the company Rebranded as Aitia)
8.3.1 Company Overview
8.3.2 Finanacial Performance
8.3.3 Offerings
8.3.4 Strategic Initiatives
8.4 Google (DeepMind)
8.4.1 Company Overview
8.4.2 Finanacial Performance
8.4.3 Offerings
8.4.4 Strategic Initiatives
8.5 BenevolentAI
8.5.1 Company Overview
8.5.2 Finanacial Performance
8.5.3 Offerings
8.5.4 Strategic Initiatives
8.6 BioSymetrics, Inc
8.6.1 Company Overview
8.6.2 Finanacial Performance
8.6.3 Offerings
8.6.4 Strategic Initiatives
8.7 Atomwise Inc.
8.7.1 Company Overview
8.7.2 Finanacial Performance
8.7.3 Offerings
8.7.4 Strategic Initiatives
8.8 Berg Health (In January 2023, BPGbio Inc. acquired Berg Health)
8.8.1 Company Overview
8.8.2 Finanacial Performance
8.8.3 Offerings
8.9.4 Strategic Initiatives
8.10 insitro
8.10.1 Company Overview
8.10.2 Finanacial Performance
8.10.3 Offerings
8.10.4 Strategic Initiatives
8.11 CYCLICA (In May 2023, CYCLICA acquired by Recursion)
8.11.1 Company Overview
8.11.2 Finanacial Performance
8.11.3 Offerings
8.11.4 Strategic Initiatives
List of Tables
Table 1 Partial list of secondary sources
Table 2 North America Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 3 North America Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 4 U.S. Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 5 U.S. Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 6 Canada Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 7 Canada Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 8 Mexico Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 9 Mexico Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 10 Europe Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 11 Europe Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 12 UK Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 13 UK Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 14 Germany Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 15 Germany Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 16 France Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 17 France Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 18 Spain Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 19 Spain Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 20 Italy Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 21 Italy Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 22 Denmark Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 23 Denmark Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 24 Sweden Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 25 Sweden Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 26 Norway Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 27 Norway Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 29 Asia Pacific Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 30 China Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 31 China Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 32 India Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 33 India Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 34 Japan Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 35 Japan Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 36 Australia Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 37 Australia Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 38 South Korea Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 39 South Korea Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 40 Latin America Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 41 Latin America Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 42 Brazil Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 43 Brazil Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 44 Argentina Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 45 Argentina Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 46 Middle East & Africa Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 47 Middle East & Africa Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 48 South Africa Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 49 South Africa Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 50 Saudi Arabia Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 51 Saudi Arabia Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 52 UAE Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 53 UAE Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
Table 54 Kuwait Artificial Intelligence drug discovery market, by application, 2018 - 2030 (USD Million)
Table 55 Kuwait Artificial Intelligence drug discovery market, by therapeutic area, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Global Artificial Intelligence in drug discovery market snapshot, 2021 (USD Million)
Fig. 9 Global Artificial Intelligence in drug discovery market segmentation
Fig. 10 Global Artificial Intelligence in drug discovery market dynamics
Fig. 11 Global Artificial Intelligence in drug discovery market driver impact
Fig. 12 Global Artificial Intelligence in drug discovery market restraints impact
Fig. 13 Global Artificial Intelligence in drug discovery market - PESTLE analysis
Fig. 14 Global Artificial Intelligence in drug discovery market - Porter’s Analysis
Fig. 15 Global Artificial Intelligence in drug discovery market - Application outlook and key takeaways
Fig. 16 Global Artificial Intelligence in drug discovery market - Application movement analysis
Fig. 17 Drug optimization and repurposing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Preclinical testing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Global Artificial Intelligence in drug discovery market - Therapeutic area outlook and key takeaways
Fig. 21 Global Artificial Intelligence in drug discovery market - Therapeutic area movement analysis
Fig. 22 Oncology market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Neurodegenerative Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Cardiovascular Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Metabolic Diseases market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Infectious Disease market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Global Artificial Intelligence in drug discovery market - Regional outlook and key takeaways
Fig. 29 Global Artificial Intelligence in drug discovery market - Regional movement analysis
Fig. 30 North America Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 U.S. Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Canada Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Mexico Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Europe Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 U.K. Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Germany Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 France Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Spain Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Italy Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Denmark Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Sweden Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Norway Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Asia Pacific Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 China Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 India Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Japan Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Australia Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 South Korea Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Latin America Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Brazil Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Argentina Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Middle East & Africa Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53. South Africa Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Saudi Arabia Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 UAE Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Kuwait Artificial Intelligence in drug discovery estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Recent Developments & Impact Analysis, By Key Market Participants
Fig. 58 Company market position analysis, 2023
Fig. 59 Strategic alliance and deals analysis

Companies Mentioned

  • IBM
  • Exscientia
  • Insilico Medicine
  • GNS Healthcare (In January 2023, the company Rebranded as Aitia)
  • Google (DeepMind)
  • BenevolentAI
  • BioSymetrics, Inc.
  • Berg Health (In January 2023, Berg Health acquired by BPGbio Inc.)
  • Atomwise Inc.
  • insitro
  • CYCLICA (In May 2023, CYCLICA acquired by Recursion)

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages80
PublishedJuly 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 1.5 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.1 Billion
Compound Annual Growth Rate29.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Artificial Intelligence in Drug Discovery Market by Offering, Technology, Process, Application, Therapeutic Area, End User - Global Forecast 2025-2030 - Product Image

Artificial Intelligence in Drug Discovery Market by Offering, Technology, Process, Application, Therapeutic Area, End User - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Artificial Intelligence (AI) In Drug Discovery - Market Insight, Competitive Landscape And Market Forecast - 2030 - Product Image

Artificial Intelligence (AI) In Drug Discovery - Market Insight, Competitive Landscape And Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Artificial Intelligence (AI) in Drug Discovery - Global Strategic Business Report - Product Image

Artificial Intelligence (AI) in Drug Discovery - Global Strategic Business Report

  • Report
  • 219 Pages
  • Global
From
Artificial Intelligence In Drug Discovery Market Analysis & Forecast to 2024-2034: Market By Component; By Technology; By Therapeutic Area; By Application; By End-user; and By Region - Product Image

Artificial Intelligence In Drug Discovery Market Analysis & Forecast to 2024-2034: Market By Component; By Technology; By Therapeutic Area; By Application; By End-user; and By Region

  • Report
  • 200 Pages
  • Global
From
Artificial Intelligence (AI) in Drug Discovery Global Market Report 2024 - Product Image

Artificial Intelligence (AI) in Drug Discovery Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.